Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Dave Parker |
|---|---|
| Location: | Redhill, Surrey |
| Users: | 14 |
| Nodes: | 16 (0 / 16) |
| Uptime: | 15:06:11 |
| Calls: | 167 |
| Calls today: | 1 |
| Files: | 12 |
| D/L today: |
1 files (171K bytes) |
| Messages: | 32,442 |